Close

Dr Pamela Minicozzi

Assistant Professor

LSHTM
Keppel Street
London
WC1E 7HT
United Kingdom

Dr Pamela Minicozzi graduated in Applied Mathematics from the University of Pavia (Italy) in 2006, then completed a Master in Medical Statistics and Statistical Methods for Epidemiology at the University of Milan (Italy) in 2009, followed by a PhD in Public Health and Educational Science in 2012 at the University of Pavia (Italy), and a Master in Business Intelligence and Big Data Analytics at the University of Milan-Bicocca in 2018.

She was a Research Fellow in the Molecular Ecotossicology Unit, Department of Environmental Science and Life in Alessandria (Italy) in 2007. From 2007 to 2019, she worked as a Research Fellow in the Epidemiology Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milan (Italy), on EUROCARE (European Cancer Registry-based study of survival and care of cancer patients) and related studies, like among others the European High Resolution Studies on inequalities in survival from breast, colorectal, and lung cancers, skin melanoma and haematological malignancies. She has been working in the Cancer Survival Group at LSHTM since August 2019.

Affiliations

Department of Non-communicable Disease Epidemiology
Faculty of Epidemiology and Population Health

Teaching

Pamela teaches on the Basic Epidemiology module in Term 1, and the Statistical Methods for Epidemiology (SME) and Survival Analysis modules in Term 2. She is also involved in the supervision of the Distance Learning MSc Epidemiology Projects.

Research

She is currently working on the CONCORD programme, focused on the international comparisons of cancer survival, and on the VENUSCANCER project, analysing more in deep the inequalities in survival from cancers of the breast, cervix and ovary.

Research Area
Health inequalities
Public health
Statistical methods
Discipline
Epidemiology
Disease and Health Conditions
Cancer
Region
World

Selected Publications

Worldwide trends in population-based survival for children, adolescents, and young adults diagnosed with leukaemia, by subtype, during 2000-14 (CONCORD-3): analysis of individual data from 258 cancer registries in 61 countries.
Ssenyonga N; Stiller C; Nakata K; Shalkow J; Redmond S; Bulliard J-L; Girardi F; Fowler C; Marcos-Gragera R; Bonaventure A
2022
The Lancet Child & Adolescent Health
Clear Improvement in Real-World Chronic Myeloid Leukemia Survival: A Comparison With Randomized Controlled Trials.
Vener C; Rossi S; Minicozzi P; Marcos-Gragera R; Poirel HA; Maynadié M; Troussard X; Pravettoni G; De Angelis R; Sant M
2022
Frontiers in oncology
Differences in the management and survival of metastatic colorectal cancer in Europe. A population-based study.
Bouvier A-M; Jooste V; Sanchez-Perez MJ; Bento MJ; Rocha Rodrigues J; Marcos-Gragera R; Carmona-Garcia MC; Luque-Fernandez MA; Minicozzi P; Bouvier V
2021
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
Is short-term survival from metastatic cutaneous melanoma improving? Results from 22 countries (CONCORD-3).
Di Carlo V; Matz M; Minicozzi P; Ssenyonga N; Coleman M; Allemani C
2021
The economic burden of colorectal cancer across Europe: a population-based cost-of-illness study.
Henderson RH; French D; Maughan T; Adams R; Allemani C; Minicozzi P; Coleman MP; McFerran E; Sullivan R; Lawler M
2021
The lancet. Gastroenterology & hepatology
World-wide trends in survival for children, adolescents and young adults (0-24 years) diagnosed with leukaemia during 2000-2014 in 61 countries (CONCORD-3).
Ssenyonga N; Di Carlo V; Girardi F; Matz M; Minicozzi P; Coleman M; Allemani C
2021
Olfactory signals and fertility in olive baboons.
Vaglio S; Minicozzi P; Kessler SE; Walker D; Setchell JM
2021
Scientific reports
Bratislava Statement: consensus recommendations for improving pancreatic cancer care.
Prades J; Arnold D; Brunner T; Cardone A; Carrato A; Coll-Ortega C; De Luze S; Garel P; Goossens ME; Grilli R
2020
ESMO OPEN
See more Publications